Literature DB >> 23335793

Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome.

Janice V Huang1, Li Lu, Shuyu Ye, Bryan C Bergman, Genevieve C Sparagna, Mohammad Sarraf, Jane E B Reusch, Clifford R Greyson, Gregory G Schwartz.   

Abstract

Clinical metabolic syndrome conveys a poor prognosis in patients with acute coronary syndrome, not fully accounted for by the extent of coronary atherosclerosis. To explain this observation, we determined whether postischemic myocardial contractile and metabolic function are impaired in a porcine dietary model of metabolic syndrome without atherosclerosis. Micropigs (n = 28) were assigned to a control diet (low fat, no added sugars) or an intervention diet (high saturated fat and simple sugars, no added cholesterol) for 7 mo. The intervention diet produced obesity, hypertension, dyslipidemia, and impaired glucose tolerance, but not atherosclerosis. Under open-chest, anesthetized conditions, pigs underwent 45 min of low-flow myocardial ischemia and 120 min of reperfusion. In both diet groups, contractile function was similar at baseline and declined similarly during ischemia. However, after 120 min of reperfusion, regional work recovered to 21 ± 12% of baseline in metabolic syndrome pigs compared with 61 ± 13% in control pigs (P = 0.01). Ischemia-reperfusion caused a progressive decline in mechanical/metabolic efficiency (regional work/O2 consumption) in metabolic syndrome hearts, but not in control hearts. Metabolic syndrome hearts demonstrated altered fatty acyl composition of cardiolipin and increased Akt phosphorylation in both ischemic and nonischemic regions, suggesting tonic activation. Metabolic syndrome hearts used more fatty acid than control hearts (P = 0.03). When fatty acid availability was restricted by prior insulin exposure, differences between groups in postischemic contractile recovery and mechanical/metabolic efficiency were eliminated. In conclusion, pigs with characteristics of metabolic syndrome demonstrate impaired contractile and metabolic recovery after low-flow myocardial ischemia. Contributory mechanisms may include remodeling of cardiolipin, abnormal activation of Akt, and excessive utilization of fatty acid substrates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335793      PMCID: PMC3602770          DOI: 10.1152/ajpheart.00535.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  62 in total

1.  Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique.

Authors:  C P Reinhardt; S Dalhberg; M A Tries; R Marcel; J A Leppo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-01       Impact factor: 4.733

2.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

Authors:  Jonathan Buchanan; Pradip K Mazumder; Ping Hu; Gopa Chakrabarti; Matthew W Roberts; Ui Jeong Yun; Robert C Cooksey; Sheldon E Litwin; E Dale Abel
Journal:  Endocrinology       Date:  2005-09-01       Impact factor: 4.736

3.  Fructose-fed rat hearts are protected against ischemia-reperfusion injury.

Authors:  Marie Joyeux-Faure; Eliane Rossini; Christophe Ribuot; Patrice Faure
Journal:  Exp Biol Med (Maywood)       Date:  2006-04

4.  The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs.

Authors:  Ya Xu; Li Lu; Clifford Greyson; Mona Rizeq; Karin Nunley; Beata Wyatt; Michael R Bristow; Carlin S Long; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-12-09       Impact factor: 4.733

5.  Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia.

Authors:  Antonio D Lassaletta; Louis M Chu; Michael P Robich; Nassrene Y Elmadhun; Jun Feng; Thomas A Burgess; Roger J Laham; Michael Sturek; Frank W Sellke
Journal:  Basic Res Cardiol       Date:  2012-01-10       Impact factor: 17.165

6.  Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.

Authors:  Salvatore Pepe; Peter L McLennan
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

7.  Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart.

Authors:  Takashi Matsui; Ling Li; Justina C Wu; Stuart A Cook; Tomohisa Nagoshi; Michael H Picard; Ronglih Liao; Anthony Rosenzweig
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

8.  Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.

Authors:  Leonardo C Clavijo; Tina L Pinto; Pramod K Kuchulakanti; Rebecca Torguson; William W Chu; Lowell F Satler; Kenneth M Kent; William O Suddath; Augusto D Pichard; Ron Waksman
Journal:  Cardiovasc Revasc Med       Date:  2006 Jan-Mar

9.  Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet.

Authors:  Melissa C Dyson; Mouhamad Alloosh; James P Vuchetich; Eric A Mokelke; Michael Sturek
Journal:  Comp Med       Date:  2006-02       Impact factor: 0.982

10.  Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

Authors:  Robert J Sidell; Mark A Cole; Nicholas J Draper; Martine Desrois; Robin E Buckingham; Kieran Clarke
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

View more
  4 in total

1.  Effect of Obesity or Metabolic Syndrome and Diabetes on Osseointegration of Dental Implants in a Miniature Swine Model: A Pilot Study.

Authors:  Paulo G Coelho; Benjamin Pippenger; Nick Tovar; Sietse-Jan Koopmans; Natalie M Plana; Dana T Graves; Steve Engebretson; Heleen M M van Beusekom; Paula G F P Oliveira; Michel Dard
Journal:  J Oral Maxillofac Surg       Date:  2018-03-01       Impact factor: 1.895

2.  Metformin prevents ischaemic ventricular fibrillation in metabolically normal pigs.

Authors:  Li Lu; Shuyu Ye; Rebecca L Scalzo; Jane E B Reusch; Clifford R Greyson; Gregory G Schwartz
Journal:  Diabetologia       Date:  2017-05-11       Impact factor: 10.122

3.  Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome.

Authors:  Cecilia C Low Wang; Li Lu; J Wayne Leitner; Mohammad Sarraf; Roberto Gianani; Boris Draznin; Clifford R Greyson; Jane E B Reusch; Gregory G Schwartz
Journal:  J Diabetes Complications       Date:  2013-04-02       Impact factor: 2.852

4.  Monotherapy of experimental metabolic syndrome: II. Study of cardiovascular effects.

Authors:  Vladimír Knezl; Ružena Sotníková; Zuzana Brnoliaková; Tatiana Stankovičová; Viktor Bauer; Štefan Bezek
Journal:  Interdiscip Toxicol       Date:  2018-02-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.